News Releases - 2017

NCPA Urges CMS to Ensure Robust Patient Access to Prescription Drugs in State Health Exchanges

by NCPA | Nov 28, 2017

ALEXANDRIA, Va. (Nov. 28, 2017) — In comments to the Centers for Medicare and Medicaid Services about the Affordable Care Act proposed rule for 2019, the National Community Pharmacists Association urged the current policies for prescription drug benefits in the state exchanges be kept in place. NCPA Chief Executive Officer B. Douglas Hoey, Pharmacist, MBA, issued the following statement:

"We believe CMS must exercise caution in working with states on what constitutes an essential health benefit on the state exchanges, and more specifically, the agency must not allow for too much substitution with the formularies for prescription drug benefits.

"Prescription drug regimens are the most effective way of treating chronic or temporary health conditions. Limiting what drugs are covered undermines the therapeutic options for care. It is also important that prescription drug benefits, which are a critical component of what patients look for when choosing health plans, remain an essential health benefit in CMS' final rule."


The National Community Pharmacists Association (NCPA®) represents the interests of America's community pharmacists, including the owners of more than 22,000 independent community pharmacies. Together they represent an $80 billion health care marketplace and employ more than 250,000 individuals on a full- or part-time basis. To learn more, go to, visit, or follow NCPA on Twitter @Commpharmacy.